Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant EGFR (Zalutumumab Biosimilar) anticorps

Research Grade Reactivité: Humain ELISA Hôte: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
N° du produit ABIN7487875
  • Antigène Tous les produits EGFR (Zalutumumab Biosimilar)
    EGFR (Zalutumumab Biosimilar)
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    Humain
    Hôte
    • 1
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    Clonalité
    • 1
    • 1
    Monoclonal
    Conjugué
    • 2
    Cet anticorp EGFR (Zalutumumab Biosimilar) est non-conjugé
    Application
    • 2
    • 2
    • 2
    ELISA
    Fonction
    Zalutumumab Biosimilar - Anti-EGFR mAb
    Attributs du produit
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Classe de qualité
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Stock
    -80 °C
    Stockage commentaire
    store at -80°C
  • Antigène
    EGFR (Zalutumumab Biosimilar)
    Abstract
    EGFR (Zalutumumab Biosimilar) Produits
    Synonymes
    anticorps ERBB, anticorps ERBB1, anticorps HER1, anticorps PIG61, anticorps mENA, anticorps epidermal growth factor receptor, anticorps EGFR
    Classe de substances
    Biosimilar
    Sujet
    HuMax-EGFr
    Zalutumumab (proposed trade name HuMax-EGFR) is a high affinity, completely human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR, also known as ErbB1/HER1). It is developed by Genmab and designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. Zalutumumab is derived from transgenic mice immunized with A431-derived EGFR.
    Numéro CAS
    667901-13-5
Vous êtes ici:
Support technique